IRX3 and leukemia: In leukemia, IRX3 is overexpressed in about 30% of cases of AML, 50% of T-acute lymphoblastic leukemia, and 20% of B-acute lymphoblastic leukemia, while its expression is almost undetectable during normal hematopoiesis and in mature blood cells.11